TGF beta: A player on multiple fronts in the tumor microenvironment
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F15%3A00445710" target="_blank" >RIV/61388971:_____/15:00445710 - isvavai.cz</a>
Alternative codes found
RIV/67985904:_____/15:00457798
Result on the web
<a href="http://dx.doi.org/10.3109/1547691X.2014.945667" target="_blank" >http://dx.doi.org/10.3109/1547691X.2014.945667</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3109/1547691X.2014.945667" target="_blank" >10.3109/1547691X.2014.945667</a>
Alternative languages
Result language
angličtina
Original language name
TGF beta: A player on multiple fronts in the tumor microenvironment
Original language description
The physiological functions of transforming growth factor (TGF)-beta in cell signaling include regulation of developmental processes and cell growth. Tumor cells very often display altered regulation of the TGF beta signaling pathway, either by defects in TGF beta itself or in downstream components of the pathway. TGF beta can play a dual role in tumorigenesis, i.e. it can be either tumor-suppressive or tumor-promoting. TGF beta suppresses the growth of tumor cells; however, in advanced tumors, it is associated with induction of progression, resulting in poor prognosis for patients. The TGF beta negative regulation of cytotoxic cell function, together with the promotion of T-regulatory cell maturation, impairs anti-tumor responses. Recent studies haveelucidated new roles for TGF beta signaling in the tumor microenvironment. Abrogation of proper signaling induces epithelial-to-mesenchymal transition with pro-metastatic functions, resulting in cancer progression. Thus, TGF beta signalin
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EC - Immunology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/IAA500200917" target="_blank" >IAA500200917: Genetics and immunity in early stages of colorectal adenocarcinoma: inflammatory environment inconventional vs germ-free animal models, and in human samples</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Immunotoxicology
ISSN
1547-691X
e-ISSN
—
Volume of the periodical
12
Issue of the periodical within the volume
3
Country of publishing house
GB - UNITED KINGDOM
Number of pages
8
Pages from-to
300-307
UT code for WoS article
000353580200012
EID of the result in the Scopus database
—